A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)
Copyright policy )A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)
- Institut des Sciences Biologiques France
- Inserm France
- Hôpital Cochin France
- Institut Cochin France
- Necker-Enfants Malades Hospital France
Aged, 80 and over, Risk, Polymorphism, Genetic, Ubiquitin-Protein Ligases, CRBN gene; lenalidomide; low risk MDS, Angiogenesis Inhibitors, Middle Aged, Thalidomide, Myelodysplastic Syndromes, Biomarkers, Tumor, Humans, Chromosome Deletion, Lenalidomide, Adaptor Proteins, Signal Transducing, Aged, Peptide Hydrolases
Aged, 80 and over, Risk, Polymorphism, Genetic, Ubiquitin-Protein Ligases, CRBN gene; lenalidomide; low risk MDS, Angiogenesis Inhibitors, Middle Aged, Thalidomide, Myelodysplastic Syndromes, Biomarkers, Tumor, Humans, Chromosome Deletion, Lenalidomide, Adaptor Proteins, Signal Transducing, Aged, Peptide Hydrolases
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).30 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!